Budget Amount *help |
¥24,050,000 (Direct Cost: ¥18,500,000、Indirect Cost: ¥5,550,000)
Fiscal Year 2018: ¥7,020,000 (Direct Cost: ¥5,400,000、Indirect Cost: ¥1,620,000)
Fiscal Year 2017: ¥8,580,000 (Direct Cost: ¥6,600,000、Indirect Cost: ¥1,980,000)
Fiscal Year 2016: ¥8,450,000 (Direct Cost: ¥6,500,000、Indirect Cost: ¥1,950,000)
|
Outline of Final Research Achievements |
Cancer stem cell (CSC) have been implicated in chemo-resistance and tumor relapse, and the stem cell-like properties are regulated by CSC niche. However, the CSC niche in solid tumor is totally unknown. In the current study, we identified RHBDF2 as a gene overexpressed in cancer associated fibroblasts (CAFs), and showed that this molecule enhances gastric cancer (GC) cell invasion through oncogenic and non-canonical TGFB1 signaling. Further analysis using specific inhibitor of RHBDF2 may lead to the inhibition of GC invasion and metastasis.
|